Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Unravelling the shared genetic mechanisms underlying 18 autoimmune diseases using a systems approach

Open access
Gokuladhas, Sreemol, Schierding, William, Golovina, Evgeniia, Fadason, Tayaza, O’Sullivan, Justin · 2021 · Frontiers in Immunology

Preprint — published as 10.3389/fimmu.2021.693142 · Paper page

Abstract

Autoimmune diseases (AiDs) are complex heterogeneous diseases characterized by hyperactive immune responses against self. Genome-wide association studies have identified thousands of single nucleotide polymorphisms (SNPs) associated with several AiDs. While these studies have identified a handful of pleiotropic loci that confer risk to multiple AiDs, they lack the power to detect shared genetic factors residing outside of these loci. Here, we integrated chromatin contact, expression quantitative trait loci and protein-protein interaction (PPI) data to identify genes that are regulated by both pleiotropic and non-pleiotropic SNPs. The PPI analysis revealed complex interactions between the shared and disease-specific genes. Furthermore, pathway enrichment analysis demonstrated that the shared genes co-occur with disease-specific genes within the same biological pathways. In conclusion, our results are consistent with the hypothesis that genetic risk loci associated with multiple AiDs converge on a core set of biological processes that potentially contribute to the emergence of polyautoimmunity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2021.03.28.437437

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Global overview of the genetic architecture of AIDs. (A) SNPs associated with each of 18 AiDs (D1 to D18) were analyzed through the CoDeS3D algorithm (Fadason et al., 2018). Briefly: (i) genes that are in physical contact with the SNPs (cis - located within 1 Mb distance, trans-intrachromosomal- located on the same chromosome but more than 1 Mb apart, and trans-interchromosomal - located on the different chromosomes) within the three-dimensional organization of the nucleus are identified; and (ii) SNP-gene pairs are queried through GTEx to identify those that overlap eQTL-eGene correlations. Lastly, the regulatory SNP-gene associations identified for each of 18 AiDs were consolidated to identify the genes (1), associated with pleiotropic SNPs only, (2) associated with pleiotropic & non-pleiotropic SNPs, or >2 non-pleiotropic SNPs associated with different AiDs and, (3) associated with non-pleiotropic SNPs only. (B) Summary of pleiotropic and non-pleiotropic SNPs (left) and their target genes (right) across 18 AiDs by proportion. Dotted lines indicate associations between categories of SNPs and genes. (C) The proportion of genes regulated in cis, trans (inter- and/or intra-chromosomal), or both cis and trans by the SNPs across 18 AiDs. (D) Trans-regulatory connections were enriched in single tissue. Proportion of genes was calculated as percentage total genes.
Figure 1 Global overview of the genetic architecture of AIDs. (A) SNPs associated with each of 18 AiDs (D1 to D18) were analyzed through the CoDeS3D algorithm (Fadason et al., 2018). Briefly: (i) genes that are in physical contact with the SNPs (cis - located within 1 Mb distance, trans-intrachromosomal- located on the same chromosome but more than 1 Mb apart, and trans-interchromosomal - located on the different chromosomes) within the three-dimensional organization of the nucleus are identified; and (ii) SNP-gene pairs are queried through GTEx to identify those that overlap eQTL-eGene correlations. Lastly, the regulatory SNP-gene associations identified for each of 18 AiDs were consolidated to identify the genes (1), associated with pleiotropic SNPs only, (2) associated with pleiotropic & non-pleiotropic SNPs, or >2 non-pleiotropic SNPs associated with different AiDs and, (3) associated with non-pleiotropic SNPs only. (B) Summary of pleiotropic and non-pleiotropic SNPs (left) and their target genes (right) across 18 AiDs by proportion. Dotted lines indicate associations between categories of SNPs and genes. (C) The proportion of genes regulated in cis, trans (inter- and/or intra-chromosomal), or both cis and trans by the SNPs across 18 AiDs. (D) Trans-regulatory connections were enriched in single tissue. Proportion of genes was calculated as percentage total genes.CC BY · PubMed Central
Figure 2 Overview of the functional modules identified from Ai-PPIN. (A) Schematic representation of the Ai-PPIN module analysis. The Louvain community detection algorithm (18) was applied to detect communities/modules within the Ai-PPIN network. Statistically significant (qs-test) (21) modules (yellow bubble) were identified by comparison with modules from 10000 random networks. Non-significant modules (red bubble) were excluded from further analysis. Functional enrichment analyses using KEGG pathways and GO : BP (gene ontology biological process terms) were performed to identify the biological functions enriched within each module. (B) The Ai-PPIN contains fourteen significant modules. In each module, the nodes represent proteins. The lines connecting the nodes represent interactions between proteins. N and E denotes the number of nodes and edges present in each module respectively. The p-value denotes the statistical significance of the modules (qs-test) (21). Cytoscape (version 3.8.2) was used for visualization of the network.
Figure 2 Overview of the functional modules identified from Ai-PPIN. (A) Schematic representation of the Ai-PPIN module analysis. The Louvain community detection algorithm (18) was applied to detect communities/modules within the Ai-PPIN network. Statistically significant (qs-test) (21) modules (yellow bubble) were identified by comparison with modules from 10000 random networks. Non-significant modules (red bubble) were excluded from further analysis. Functional enrichment analyses using KEGG pathways and GO : BP (gene ontology biological process terms) were performed to identify the biological functions enriched within each module. (B) The Ai-PPIN contains fourteen significant modules. In each module, the nodes represent proteins. The lines connecting the nodes represent interactions between proteins. N and E denotes the number of nodes and edges present in each module respectively. The p-value denotes the statistical significance of the modules (qs-test) (21). Cytoscape (version 3.8.2) was used for visualization of the network.CC BY · PubMed Central
Figure 3 Shared genes display predominant role in AiD modules. (A) Heatmap of proportion of genes/proteins from each AiD that were attributed to modules 1-14. Dark shaded square indicates higher proportions of proteins. (B) The proportion of shared, disease-specific and identical proteins present in the top 5 enriched biological pathways (KEGG), by module. (C) The proportion of disease-specific, shared and identical proteins that constitutes central nodes within each module. (D) The central proteins in 13 modules are targeted by FDA approved drugs, of which 45% proteins are shared between diseases. Proteins that are targeted by more than 20 drugs are labeled.
Figure 3 Shared genes display predominant role in AiD modules. (A) Heatmap of proportion of genes/proteins from each AiD that were attributed to modules 1-14. Dark shaded square indicates higher proportions of proteins. (B) The proportion of shared, disease-specific and identical proteins present in the top 5 enriched biological pathways (KEGG), by module. (C) The proportion of disease-specific, shared and identical proteins that constitutes central nodes within each module. (D) The central proteins in 13 modules are targeted by FDA approved drugs, of which 45% proteins are shared between diseases. Proteins that are targeted by more than 20 drugs are labeled.CC BY · PubMed Central
Figure 4 HLA genes are central to immune function rich module. (A) Network representation of Module 1. The color of the nodes denotes the disease with which the protein is associated. Node shape indicates if the SNP acts locally (cis - circle), distally (trans - diamond), or both (cis and trans – rounded square) on the genes encoding proteins. Central nodes are highlighted in red borders and labelled. Cytoscape (version 3.8.2) was used for visualization of the module. (B) Relatively greater proportions of proteins (>40%) in the Module 1 are enriched for transport, localization and immune processes. The top 30 enrichment results are shown (FDR ≤ 6.01e-14) (C) KEGG pathway enrichment analysis identified enrichment in immune related pathways (FDR<0.05). In (B, C), the numbers on top of each bar denote the number of proteins enriched for that term/pathway, and the asterisk denotes that the term/pathway is also enriched for shared proteins that are central to the network (Supplementary Data 10 Tables 4, 5).
Figure 4 HLA genes are central to immune function rich module. (A) Network representation of Module 1. The color of the nodes denotes the disease with which the protein is associated. Node shape indicates if the SNP acts locally (cis - circle), distally (trans - diamond), or both (cis and trans – rounded square) on the genes encoding proteins. Central nodes are highlighted in red borders and labelled. Cytoscape (version 3.8.2) was used for visualization of the module. (B) Relatively greater proportions of proteins (>40%) in the Module 1 are enriched for transport, localization and immune processes. The top 30 enrichment results are shown (FDR ≤ 6.01e-14) (C) KEGG pathway enrichment analysis identified enrichment in immune related pathways (FDR<0.05). In (B, C), the numbers on top of each bar denote the number of proteins enriched for that term/pathway, and the asterisk denotes that the term/pathway is also enriched for shared proteins that are central to the network (Supplementary Data 10 Tables 4, 5).CC BY · PubMed Central
Figure 5 Non-HLA proteins organize into a module enriched for immune responses. (A) Network representation of Module 5. The color of the nodes denotes the disease with which the protein is associated. Node shape indicates if the SNP acts locally (cis - circle), distally (trans - diamond), or both (cis and trans – rounded square) on the genes encoding proteins. Central nodes are highlighted in red borders and labelled. Cytoscape (version 3.8.2) was used for visualization of the module. (B) Module 5 is highly enriched for immune processes. The top 30 enrichment results are shown (FDR ≤ 5.6e-09) (C) KEGG pathway enrichment results with FDR<0.05 is shown. In (B, C), the numbers, to the right of each bar, denote the number of proteins enriched for that term or pathway. The asterisk designates terms or pathways that were also enriched for shared proteins that are central to the network (Supplementary Data 11 Tables 4, 5 respectively).
Figure 5 Non-HLA proteins organize into a module enriched for immune responses. (A) Network representation of Module 5. The color of the nodes denotes the disease with which the protein is associated. Node shape indicates if the SNP acts locally (cis - circle), distally (trans - diamond), or both (cis and trans – rounded square) on the genes encoding proteins. Central nodes are highlighted in red borders and labelled. Cytoscape (version 3.8.2) was used for visualization of the module. (B) Module 5 is highly enriched for immune processes. The top 30 enrichment results are shown (FDR ≤ 5.6e-09) (C) KEGG pathway enrichment results with FDR<0.05 is shown. In (B, C), the numbers, to the right of each bar, denote the number of proteins enriched for that term or pathway. The asterisk designates terms or pathways that were also enriched for shared proteins that are central to the network (Supplementary Data 11 Tables 4, 5 respectively).CC BY · PubMed Central
Figure 6 The largest network module is enriched for cellular signaling and cancer pathways. (A) Network representation of the module. The color of the nodes denotes the disease with which the protein is associated. Node shape indicates if the SNP acts locally (cis - circle), distally (trans - diamond), or both (cis and trans – rounded square) on the genes encoding proteins. Central nodes are highlighted in red borders and labelled. Cytoscape (version 3.8.2) was used for visualization of the module. (B) Module 7 is enriched for signaling and metabolic processes. The top 30 enrichment results are shown (FDR ≤ 4.77E-36). (C) KEGG pathway enrichment analysis identified enrichment in signaling and cancer related pathways (FDR ≤ 3.70E-09). The top 30 pathway enrichment results are shown. In (B, C), the numbers, to the right of each bar, denote the number of proteins enriched for that term or pathway. The asterisk designates terms or pathways that were enriched for shared proteins that are central to the network (Supplementary Data 12 Tables 4, 5 respectively).
Figure 6 The largest network module is enriched for cellular signaling and cancer pathways. (A) Network representation of the module. The color of the nodes denotes the disease with which the protein is associated. Node shape indicates if the SNP acts locally (cis - circle), distally (trans - diamond), or both (cis and trans – rounded square) on the genes encoding proteins. Central nodes are highlighted in red borders and labelled. Cytoscape (version 3.8.2) was used for visualization of the module. (B) Module 7 is enriched for signaling and metabolic processes. The top 30 enrichment results are shown (FDR ≤ 4.77E-36). (C) KEGG pathway enrichment analysis identified enrichment in signaling and cancer related pathways (FDR ≤ 3.70E-09). The top 30 pathway enrichment results are shown. In (B, C), the numbers, to the right of each bar, denote the number of proteins enriched for that term or pathway. The asterisk designates terms or pathways that were enriched for shared proteins that are central to the network (Supplementary Data 12 Tables 4, 5 respectively).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 34

  1. 10.1126/science.aaz1776 · DOI · Paper page
  2. 10.1016/j.autrev.2012.02.002 · DOI
  3. 2019, High prevalence of comorbid autoimmune diseases in adults with type 1 diabetes from the HealthFacts database, Journal of Diabetes, 11, 273, 10.1111/1753-0407.12856 · DOI
  4. Blondel, V. D. , Guillaume, J. L. , Lambiotte, R. , & Lefebvre, E. (2008). Fast unfolding of communities in large networks. Journal of Statistical Mechanics: Theory and Experiment, 2008(10). https://doi.org/10.1088/1742-5468/2008/10/P10008 · DOI · Paper page
  5. 10.1016/j.jaut.2011.11.003 · DOI · Paper page
  6. 10.1093/nar/gkx1143 · DOI · Paper page
  7. Cruz-Tapias, P. , Pérez-Fernández, O. M. , Rojas-Villarraga, A. , Rodríguez-Rodríguez, A. , Arango, M. T. , & Anaya, J. M. (2012). Shared HLA class II in six autoimmune diseases in Latin America: A meta-analysis. Autoimmune Diseases, 1(1). https://doi.org/10.1155/2012/569728 · DOI
  8. Dugué, N. , & Perez, A. (2015). Directed Louvain: maximizing modularity in directed networks, (November), 0–14. Retrieved from https://hal.archives-ouvertes.fr/hal-01231784
  9. 10.1038/ng.3528 · DOI · Paper page
  10. 2018, Chromatin interactions and expression quantitative trait loci reveal genetic drivers of multimorbidities, Nature Communications, 9, 1
  11. 2008, Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseases, Journal of Autoimmune Diseases, 5, 1, 10.1186/1740-2557-5-1 · DOI
  12. 2017, Cancer and autoimmune diseases, Autoimmunity Reviews, 16, 1049, 10.1016/j.autrev.2017.07.022 · DOI · Paper page
  13. 10.1073/pnas.0701361104 · DOI · Paper page
  14. 2018, A generalised significance test for individual communities in networks, Scientific Reports, 8, 1
  15. 2019, Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis, Genes and Immunity, 20, 281, 10.1038/s41435-018-0034-z · DOI
  16. 2008, Autoimmune diseases: Insights from genome-wide association studies, Human Molecular Genetics, 17, 116, 10.1093/hmg/ddn246 · DOI · Paper page
  17. Li, M. , Wu, X. , Wang, J. , & Pan, Y. (2012). Towards the identification of protein complexes and functional modules by integrating PPI network and gene expression data. BMC Bioinformatics, 13(1). https://doi.org/10.1186/1471-2105-13-109 · DOI
  18. 10.2337/dc19-2429 · DOI
  19. Matzaraki, V. , Kumar, V. , Wijmenga, C. , & Zhernakova, A. (2017). The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biology, 18(1). https://doi.org/10.1186/s13059-017-1207-1 · DOI · Paper page
  20. Nicolae, D. L. , Gamazon, E. , Zhang, W. , Duan, S. , Eileen Dolan, M. , & Cox, N. J. (2010). Trait-associated SNPs are more likely to be eQTLs: Annotation to enhance discovery from GWAS. PLoS Genetics, 6(4). https://doi.org/10.1371/journal.pgen.1000888 · DOI · Paper page
  21. Ordoñez-Cañizares, M. C. , Mena-Vázquez, N. , Redondo-Rodriguez, R. , Manrique-Arija, S. , Jimenez-Núñez, F. G. , Ureña-Garnica, I. , & Fernández-Nebro, A. (2020). Frequency of Polyautoimmunity in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus. JCR: Journal of Clinical Rheumatology, Publish Ah(00), 1–6. https://doi.org/10.1097/rhu.0000000000001574 · DOI
  22. 10.1136/jmg.2006.041376 · DOI · Paper page
  23. 10.1186/s12859-019-2669-9 · DOI · Paper page
  24. 10.1177/1352458508096869 · DOI
  25. 10.1038/nbt.4096 · DOI · Paper page
  26. 10.1016/j.autrev.2005.06.009 · DOI
  27. 2014, A disease module in the interactome explains disease heterogeneity, drug response and captures novel pathways and genes in asthma, Human Molecular Genetics, 24, 3005
  28. 2020, Prevalence of co-existing autoimmune disease in juvenile idiopathic arthritis: A cross-sectional study, Pediatric Rheumatology, 18, 1
  29. 2017, Prevalence of Co-existing Autoimmune Disease in Rheumatoid Arthritis: A Cross-Sectional Study, Advances in Therapy, 34, 2481, 10.1007/s12325-017-0627-3 · DOI
  30. 10.1097/01.ede.0000193605.93416.df · DOI · Paper page
  31. 10.1093/nar/gky1131 · DOI · Paper page
  32. Wang, Hai-long , Zhou, Y. , Zhu, G. , Yang, Z. , & Hua, B. (2018). Malignancy as a comorbidity in rheumatic diseases: a retrospective hospital-based study, 81–85. https://doi.org/10.1007/s10067-017-3676-8 · DOI
  33. 10.1186/1471-2164-11-6 · DOI
  34. 10.1038/nature13319 · DOI · Paper page

Metadata

Authors
Gokuladhas, S., Schierding, W., Golovina, E., Fadason, T., & O’Sullivan, J.
Affiliations
University of Auckland (NZ)
Venue
Frontiers in Immunology
Publisher
openRxiv
Published
2021-03-29
Volume
12
Pages
693142-693142
ISSN
1664-3224 (ISSN-L)
OpenAlex
W3195527362
Cited by
26
References
1
Citations by year
2026: 4 · 2025: 3 · 2024: 5 · 2023: 3 · 2022: 9 · 2021: 2
FWCI
2.69
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Royal Society Te Apārangi (16-UOO-072)
  • Auckland Medical Research Foundation (ID 1320002, 1320002)
  • Ministry of Business, Innovation and Employment (UOAX1611)
  • National Institutes of Health
  • Marsden Fund (16-UOO-072)
  • National Heart, Lung, and Blood Institute
  • National Institute of Mental Health
  • National Institute on Drug Abuse
  • National Human Genome Research Institute
  • NIH Office of the Director
  • National Cancer Institute
  • National Institute of Neurological Disorders and Stroke
  • Common Fund
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Keywords
autoimmune disease, shared genetic mechanisms, polyautoimmunity, pleiotropic loci, chromatin interactions, expression quantitative trait loci, protein-protein interaction, pathway enrichment, disease risk loci, systems genetics
MeSH terms
Autoimmune Diseases, Humans, Phenotype, Autoimmunity, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Genomics, Databases, Genetic, Quantitative Trait Loci, Systems Biology, Gene Regulatory Networks, Protein Interaction Maps

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Unravelling the shared genetic mechanisms underlying 18 autoimmune diseases using a systems approach. https://app.cochat.ai/papers/10.1101/2021.03.28.437437
The paper
Gokuladhas, S., Schierding, W., Golovina, E., Fadason, T., & O’Sullivan, J. (2021). Unravelling the shared genetic mechanisms underlying 18 autoimmune diseases using a systems approach. Frontiers in Immunology. https://doi.org/10.1101/2021.03.28.437437

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.